Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Third-party verification is our standard
WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances: Both listed under Section S0 (Non-Approved Substances) Prohibited at all times (in and out of competition) No Therapeutic Use Exemptions (TUEs) available for either peptide Detection methods under development for anti-doping testing TB-500 and thymosin beta-4 explicitly banned since 2011 WADAs position reflects that neither peptide has regulatory approval from any health authority worldwide
Higher-quality formulations ensure safety, consistency, and optimal efficacy compared to generic or unregulated alternatives
Potential Interactions of AOD9604 with Adrenergic Receptors Further research on the topic suggests that prolonged experimentation protocols with AOD9604 may prime fat cells for supported fat breakdown by interacting with the adrenergic system, particularly the -adrenergic receptors (-AR), which serve as the primary lipolytic switches in fat cells
By purchasing from SYD Peptides Hub, the purchaser acknowledges and agrees that all products will be used solely for legitimate research and scientific purposes and that appropriate safety procedures and handling protocols will be followed at all times
Once transitioned into a liquid solution, the peptide blend exhibits heightened sensitivity to physical shear stress and thermal degradation
